Efficacy and Safety of Jinshuibao Capsule on Diabetic Kidney Disease
A phase 2/3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 202 participants.
Also called NCT03164785
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 2/3
- Enrolled
- 202 participants
- Registry
-
NCT03164785
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- China
- Registry status
- Completed
Technical summary
Registry record NCT03164785. Randomized; no masking; primary purpose treatment. Start 2017-07-24 (actual); primary completion 2020-09-26 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Efficacy and Safety of Jinshuibao Capsule on Diabetic Kidney Disease
- Condition
- Type 2 Diabetes Mellitus
- Condition
- Diabetic Kidney Disease
- Intervention (Drug)
- Jinshuibao Capsule
- Lead sponsor
- Second Xiangya Hospital of Central South University
Record details
- Record id
cardio:ct-nct03164785- Content hash
7c0d243d647cb83efc8bc76e592e9d08e0ea80e1459baf6f35879e02a70c2411